Navigation Links
Oxygen Biotherapeutics, Inc. Signs Supply Agreement for Clinical-Grade Oxycyte for Clinical Trials and Future Needs
Date:4/14/2009

COSTA MESA, Calif., April 14 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBO) today announced it has reached a development and commercial supply agreement with Hospira Inc.'s One 2 One(R) Global Pharmaceutical Services business unit to manufacture clinical-grade Oxycyte(R). Oxycyte is the company's perfluorocarbon (PFC) therapeutic oxygen carrier. Oxycyte will be manufactured at Hospira's Clayton, North Carolina, facility which specializes in emulsion technology.

Hospira will formulate, fill, finish and label Oxycyte to meet clinical good manufacturing practice (GMP) standards required for use of drugs in human patients. The amount of Oxycyte supplied by Hospira will be sufficient to meet any expected demand for the foreseeable future.

"This agreement connects us to a first-tier contract manufacturer and superbly reliable supplier who will provide us with all the Oxycyte we need to grow the company. As I've previously stated, our strategy is to license marketing rights for individual indications, yet always control the supply of our compound and be able to profit from sales of Oxycyte to licensees," said Chris J. Stern, company chairman and CEO.

The companies are not disclosing the financial terms of the supply agreement.

About Oxygen Biotherapeutics, Inc.

Oxygen Biotherapeutics, Inc. is dedicated to commercializing innovative pharmaceuticals and medical devices in the field of oxygen therapeutics and continuous substrate monitoring. The company has under development a perfluorocarbon therapeutic oxygen carrier and liquid ventilation product (Oxycyte(R)) and an implantable glucose sensor. These products are based upon core technologies that include biomedical applications for PFCs and medical and industrial applications for biosensors. Each of the product candidates is designed with advantages over currently marketed products in major markets includin
'/>"/>

SOURCE Oxygen Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Oxygen Biotherapeutics, Inc. CEO Posts New Blog Entry
2. Webcast Alert: Oxygen Biotherapeutics, Inc. Investor Meeting in Zurich, Switzerland
3. Oxygen Biotherapeutics, Inc. Adds Oxycyte TBI Clinical Trial Sites in Israel
4. Oxygen Biotherapeutics, Inc. Expands Board of Directors
5. Bion Announces Approval of New Australian Patent for Low Oxygen Organic Waste Bioconversion for Livestock Waste Environmental Treatment
6. Sangart, Inc. Completes Enrollment in Second Phase III Study of Hemospan, a Novel Oxygen Transport Agent
7. Finesse Introduces TruFluor(TM) DO, a Single-Use Optical Dissolved Oxygen Sensor and Transmitter
8. Senexis and O2H (Oxygen Healthcare) Announce Medicinal Chemistry Collaboration
9. Co-Inventor of Amgens Aranesp(R) Technology Directs Worldwide Patent Strategy for Diffusion Pharmaceuticals First-in-Class Oxygen Enhancing Therapeutics
10. CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership
11. CardioVascular BioTherapeutics, Inc. Announces Update on Timing of Form 10-K Filing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... OncLive® is pleased to announce that ... Strategic Alliance Partnership program. , By participating ... will have the opportunity to work with the ... research initiatives, community-directed cancer prevention programs, and other ... OncLive to educate their peers by providing insights ...
(Date:7/22/2014)... (PRWEB) July 23, 2014 The ... , The goal of the Symposium is ... spectrum of scientists working in the biomaterials field, ... that represent the most promising directions for ultimate ...     Provide faculty and government scientists with ...
(Date:7/22/2014)... in water with ultrasound and they,ll spin around their ... yet knows exactly. But researchers at the National Institute ... it,s fast. At up to 150,000 revolutions per minute, ... object submerged in liquid ever reported. , The discovery ... that they could be used not only for moving ...
(Date:7/22/2014)... 22, 2014 CTD Holdings, Inc. (OTCQB:CTDH), ... medical device, cosmetics, and other markets, announced today that ... group of qualified private investors led by Novit L.P., ... , The transaction involved the signing of a Securities ... of Common Stock at a price per share of ...
Breaking Biology Technology:OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 3The 2014 NJ Symposium on Biomaterials Science Earns Society for Biomaterials Endorsement 2NIST shows ultrasonically propelled nanorods spin dizzyingly fast 2CTD Holdings Closes $1.725 Million Private Placement 2CTD Holdings Closes $1.725 Million Private Placement 3
... March 12 Biotechnology Value Fund, L.P. ("BVF"), today announced ... Avigen, Inc. (Nasdaq: AVGN ) urging stockholders to ... them with BVF,s four new, stockholder-oriented, independent director nominees at ... 27, 2009. BVF, the beneficial owner of approximately 30% ...
... March 12 The Board of Directors of CV Therapeutics, ... careful consideration of Astellas Pharma Inc.,s $16.00 per share cash ... determined that Astellas, offer undervalues the Company and is not ... Board of Directors recommends that stockholders not tender any of ...
... in Biomarker Research, Leading to Faster Medical SolutionsWALTHAM, Mass., ... open innovation marketplace, and FasterCures ... that two InnoCentive Solvers have been awarded $5,000 each ... FasterCures posted to InnoCentive,s online network in September ...
Cached Biology Technology:Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 2Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 3Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 4Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 5Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 6Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 7Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 8Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 9CV Therapeutics' Board of Directors Rejects Astellas' Tender Offer 2CV Therapeutics' Board of Directors Rejects Astellas' Tender Offer 3FasterCures Rewards Two InnoCentive Solvers for Innovative Ideas to Accelerate Medical Research 2FasterCures Rewards Two InnoCentive Solvers for Innovative Ideas to Accelerate Medical Research 3FasterCures Rewards Two InnoCentive Solvers for Innovative Ideas to Accelerate Medical Research 4FasterCures Rewards Two InnoCentive Solvers for Innovative Ideas to Accelerate Medical Research 5
(Date:7/23/2014)... , , , , , , ... , , , , , ... proposing that changing how medical care is delivered could help prevent multiple chronic diseases and extend healthy lifespan. The idea, they argue, would be to target ... , , , , ... , , , , , ...
(Date:7/23/2014)... releases about 60 billion tons of carbon into the ... released by burning fossil fuels. This happens through a ... is balanced by carbon coming into the soil system ... as by the underground activities of plant roots. ... increase the rate of soil respiration. As a result, ...
(Date:7/23/2014)... , July 23, 2014 BioCatch, ... detection, announced today it has been named in Gartner,s ... Market Guide replaces Gartner,s well-known Magic Quadrant for Web ... BioCatch as one of several vendors to deliver passive ... will become a standard feature of at least 30% ...
Breaking Biology News(10 mins):Strategy proposed for preventing diseases of aging 2Strategy proposed for preventing diseases of aging 3Strategy proposed for preventing diseases of aging 4Strategy proposed for preventing diseases of aging 5Climate change and the soil 2BioCatch Featured in Gartner's 2014 Online Fraud Detection Market Guide 2BioCatch Featured in Gartner's 2014 Online Fraud Detection Market Guide 3
... Xie, a senior scientist at the Marshall Institute for Interdisciplinary ... National Institutes of Health to lead a project to develop ... injuries. The project will combine the expertise of two ... in bone growth and development, and his team at MIIR ...
... ancient ape species called Oreopithecus bambolii has been a ... across its swampy Mediterranean island or did it move through the ... by University of Texas at Austin anthropologists Gabrielle A. Russo and ... in fact, walk habitually on two legs. The findings ...
... treat cancer patients with drugs that kill only cancer cells ... topics in the premiere segment of the 2013 season of ... the world,s largest scientific society. The videos are available at ... Titled Prized Science: Peter Stang on Building Molecules ...
Cached Biology News:MIIR scientist awarded $293,000 NIH grant 2Extinct ancient ape did not walk like a human, study shows 2American Chemical Society launches 2013 edition of popular Prized Science video series 2
... Phosphothioate (PTO) oligonucleotides: PTOs are ... the phosphate backbone is replaced by a ... against nuclease degradation. PTOs are available as ... are phosphothioates Oligonucleotides with thio-caps ...
The mini vertical flow workbench is designed to perform PCR protocols in a particle-free environment. The built-in UV light ensures the elimination of any nucleic acid to avoid cross-contamination....
... For microsatellite research, the 4300 System ... genotyping automation software available. SagaGT automates electrophoresis, ... band sizes, and allele scoring. ,Saga GT ... LI-COR. Saga 1.0 (Unix) was initially developed ...
MOUSE ANTI GTP BINDING PROTEIN...
Biology Products: